A blueprint for a new epigenomic era
A recent effort to sequence the entire human genome also revealed how it can be modified.
Rare & Genetic Diseases
Biological body clocks reveal new paths to track and slow aging
Not only does aging affect people differently, but it also affects their organs at varying rates too.
Stem cell therapy for macular degeneration
Age-related macular degeneration is the most common cause of vision loss in adults over age 50, but there are few treatments available. Researchers are now developing promising stem cell therapies to treat the disease.
Bionic eyes: Treatments for blindness target the retina and the brain
Researchers are developing gene and cell therapies and prosthetics to help patients with blindness regain some vision. The first major prosthetic, the Argus II, was just discontinued. Where will the field go from here?
A custom CRISPR solution
Engineered particles improve the efficiency of base editor delivery.
Multiple mutations may no longer stump gene therapies
Creative solutions may enable gene therapy for more common diseases.
Ultra-rare childhood fevers are no match for this scientist
Recurrent high fevers in children are always worrying, but by studying patient cells, immunologist Lori Broderick hopes to reveal the underlying causes of these disorders.
The Promise and Reality of Stem Cell Research
LIVE March 28th, 2022 at 3:30 PM
Stem cell therapy—the holy grail of regenerative medicine—is finally entering the clinic.
Stem cell therapy—the holy grail of regenerative medicine—is finally entering the clinic.
Invisible pandemics persist alongside COVID-19
From tuberculosis to drug-resistant bacterial infections, infectious diseases that plagued the globe long before COVID-19 still affect people today.
On the road to treating mitochondrial disease
Recent advancements in mitochondrial genome editing technologies take scientists one step closer to developing viable treatments for mitochondrial diseases, which affect 1 in 4300 adults.
